1) Griffin JW, Li CY, Ho TW, et al:Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39(1):17-28 2) Willison HJ, Yuki N:Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-625 3) Hughes RA, Cornblath DR:Guillain-Barré syndrome. Lancet 2005;366(9497):1653-66 4) Beghi E, Kurland LT, Mulder DW, et al:Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine. Arch Neurol 1985;42(11):1053-7 5) ギラン・バレー症候群,フィッシャー症候群,治療ガイドライン2013,南江堂,東京,pp.82-4 6) ギラン・バレー症候群,フィッシャー症候群,治療ガイドライン2013,南江堂,東京,pp.122-3 7) Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group:Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349(9047):225-30 8) 野村恭一:AIDPをめぐる最近の話題.免疫グロブリンによるGuillain-Barré症候群の治療.神経免疫学1999;7:203-9 9) The Guillain-Barré Syndrome Study Group:Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35(8):1096-104 10) French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome:Efficiency of plasma exchange in Guillain-Barré syndrome:role of replacement fluids. Ann Neurol 1987;22(6):753-61 11) Haupt WF, Birkmann C, van der Ven C, et al:Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome. Ther Apher 2000;4(3):198-200 12) Diener HC, Haupt WF, Kloss TM, et al:A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barré syndrome. Eur Neurol 2001;46(2):107-9 13) The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome:Appropriate number of plasma exchanges in Guillain-Barré syndrome. Ann Neurol 1997;41(3):298-306 14) 王子聡,伊崎祥子,野村恭一,他:免疫性神経疾患に対する血液浄化療法による血圧の低下.日アフェレシス会誌2007;26 (Suppl 3):109